Join this event for the Annual Financing and M&A Outlook conference. Some life science sectors have seen significant disruption during the pandemic, others have experienced an upsurge in demand. However, life sciences companies will continue to thrive thanks to market demand and demographics.
Gabriele Brambilla, Chief Executive Officer, Alira Health, will be the keynote speaker. He will be joined by a panel of multidisciplinary experts from Investment banking, Private Equity Funds, and Venture Capital. Hear from these industry leaders on the latest trends in investments and transactions from 2020 and predictions for 2021.
Gabriele Brambilla, Chief Executive Officer, Alira Health
Alira Health is an international firm providing integrated strategy, execution, and innovation services for healthcare and life science companies.
Brian Johnson, President, Massachusetts Medical Device Industry Council (MassMEDIC)
Founded in 1996, MassMEDIC is the largest regional MedTech association in the United States, with over 300 members representing manufacturers, product developers, suppliers, research institutions, and academic health centers.
James Eadie, M.D., Partner, Santé Ventures
Santé invests in a diverse portfolio of innovative companies across biology, medicine, and information technology. Dr. Eadie is board-certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital.
Vincenzo di Nicola, Managing Director, Healthcare Investment Banking, Cantor Fitzgerald
Cantor Fitzgerald’s Investment Banking division offers capital raising and advisory services to both growth-oriented and mature companies. Vincenzo leads the European Healthcare Investment Banking office and co-leads the Global Pharma Outsourcing team.
Bruce C. Robertson, Ph.D., Managing Director, H.I.G. Capital
H.I.G. BioHealth Partners is the healthcare-focused affiliate of H.I.G. Capital, which collectively manages $41 billion in private capital. H.I.G. BioHealth Partners invests in a broad range of product-based healthcare companies, including pharmaceuticals, biotechnology, medical devices, and diagnostics.
Bernhard Sakmann, Senior Managing Director, Evercore
Evercore’s Strategic Advisory business provides strategic and tactical advice as well as execution to financial sponsors and both public and private companies. Dr. Sakmann has spent over 18 years in Healthcare Investment Banking and management consulting, focusing on Medical Technology, Tools, and Diagnostics companies.
Who should attend?
C-level executives, board members, investors, and other senior leaders who want a better understanding of how to make important decisions at strategic inflection points for their company in 2021.